Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Inclusion and exclusion criteria for control participants

From: Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol

Criteria List
Inclusion • Age 18–40 years.
• BMI of 20 – 45 kg/m2.
• Fluent in English.
• Have provided written informed consent.
• Current or previous diagnosis of an eating disorder or any other psychiatric diagnosis, including substance dependence.
Exclusion
• Pregnant or breast-feeding women.
• Inability to tolerate the MRI scanner due to physical or psychological factors.
• Known medical condition, disease or neurological disorder which might, in the opinion of investigator/s, interfere with the assessments to be made in the study or put subjects at increased risk.
• History of physical brain injury or blow to the head that resulted in loss of consciousness for at least 10 min.
• Prior treatment with any stimulant medication.